Pluripotent Stem Cell-Derived Therapies
Each year, more human pluripotent stem cell(hPSC)-derived therapies move toward the clinic, which is why it’s important to stay up-to-date with the latest advancements in the field. Whether you’re just about to start your next project or are well on your way to clinical trials, the big picture of clinical translation in terms of patient safety, cell quality, and physiological relevance should always be top of mind.
Below is a collection of scientific resources to highlight the exciting potential of hPSC-derived therapies.
In this Innovation Showcase presentation, Lynn Csontos demonstrates how º£½ÇÆƽâ°æ can support your project timing, product quality, and overall vision by building quality into our products, processes, and policies. Kimberly Snyder then presents data showing how TeSRâ„¢-AOF, a novel animal origin-free (AOF) hPSC maintenance medium, supports optimized cell quality, improved performance, and reproducibility across all cell lines.
Watch Now >- “ISSCR 2022: 20 Years of Excellence†Featuring Dr. Melissa Little, Keith Alm, and Dr. Amander ClarkOn this episode of the Stem Cell Podcast, Dr. Melissa Little, Keith Alm, and Dr. Amander Clark from the International Society for Stem Cell Research (ISSCR) discuss the ISSCR 2022 annual meeting, and the future of the organization and the stem cell research community.
- “Laser-Based Cell Manipulation†Featuring Dr. Marinna MadridOn this episode of the Stem Cell Podcast, Dr. Marinna Madrid from Cellino discusses how lasers and image-guided machine learning can make iPSC-derived cell therapies viable at a large scale.
- Derivation and Applications of Human Pluripotent Stem CellsOverview of the derivation of human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs)
- Cryopreservation and Thawing of Pluripotent Stem Cells: Technical Tips and Media RecommendationsTechnical tip from our dedicated team of Product and Scientific Support specialists
- Quality by Design: Reagents and Support for hPSC-Derived Cell and Gene TherapiesEach year, more human pluripotent stem cell-derived (hPSC-derived) therapies move towards the clinic, and º£½ÇÆƽâ°æ is committed to supporting researchers from discovery to clinical application. In this Innovation Showcase from ISSCR 2021, Lynn Csontos will demonstrate how we build quality into our products, processes, and policies to support your project timing, product quality, and overall vision. Kimberly Snyder will then present data that shows how TeSRâ„¢-AOF, a novel animal origin-free (AOF) hPSC maintenance medium, can support optimized cell quality, improved performance and reproducibility across all cell lines.
